Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Medical University of Silesia
Sponsor:
Collaborator:
Polpharma Pharmaceutical Company
Information provided by (Responsible Party):
Andrzej Tomasik MD PhD FESC, Medical University of Silesia
ClinicalTrials.gov Identifier:
NCT01805804
First received: March 2, 2013
Last updated: January 1, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):